|
||||
 |
||||
|
|
|
|
 |
|
|
||||||||||||||||||
 |
pressFor Interesting News on Our Companies and Our Industry please choose from the articles below. Most Articles are also available in PDF format
Jul 03, 2008
Zonare Medical Systems, Ins. Files Registration Statement For Initial Public Offering.
[More]
Feb 20, 2008
Parallel entrepreneur Mir Imran, CEO of InCube Labs, has launched twenty companies - at times simultaneously. He shares his solutions-focused expertise and identifies the vitality and growth of the biomedical healthcare vertical.
[More]
May 02, 2007
Mir Imran keynote speaker at Johns Hopkins University during BioMedical Engineering Design Day.
[More]
Nov 28, 2006
OEM AGREEMENT FOR WORLD’S FIRST CONVERTIBLE ULTRASOUND™ PLATFORM Leading Medical Firm First to Offer Revolutionary Zone Sonography™ Technology to Japanese Market
[More]
Nov 06, 2006
Intel is the big Kahuna now, but Texas Instruments is all over the digital future
[More]
Aug 14, 2006
Intrapace, Inc., a medical device company developing an implantable gastric stimulator for the treatment of Obesity, announced today that it completed a $30 million series D financing
[More]
Nov 07, 2005
There may be no better way to get a broad, deep view of what's happening in medical electronics than to sit down over coffee with Mir Imran
[More]
Aug 01, 2005
Purchase Furthers Hospira's Strategic Focus on Increased Patient Safety and Improved Hospital Productivity
[More]
Jul 21, 2004
Security screening innovator SafeView Inc. has added three new investors to its syndicate as it closed a $16 million second round of venture funding intended to support the company’s expansion as it begins to install its products in airports.
[More]
Jul 14, 2004
Intrapace, Inc. Completes Oversubscribed Series C Funding. The Company is Developing Electrilca Pacing Technology to Address the Epidemic of Obesity
[More]
Jun 30, 2001
The Boston Scientific Corporation agreed to buy the Cardiac Pathways Corporation for $115 million in cash to add to its line of products that treat abnormal heart rhythms.
[More]
Jun 29, 2001
Natick-based Boston Scientific Corp. has agreed to buy Sunnyvale, Calif.-based Cardiac Pathways Corp. for $115 million in cash to add to its line of products that treat abnormal heart rhythms
[More]
Oct 24, 2000
St. Jude Medical Inc. said yesterday that its Pacesetter subsidiary would acquire Ventritex Inc. in a stock swap valued at $505 million. Ventritex, based in Sunnyvale, Calif., is a leading maker of implantable heart defibrillators, which are small devices that deliver a jolt of electricity to stabilize a racing heart.
[More]
Oct 19, 2000
Six years ago, the stent-a metal scaffold the size of a ballpoint-pen spring-transformed the care of heart patients, creating a $2 billion product for several big medical companies. Now, another tiny device appears poised to have a similar impact, in part because it may prevent potentially serious complications caused by the stent.
[More]
Feb 05, 2000
Ken Rusk remembers the first time the titanium box in his abdomen did what it was supposed to do -- deliver an electric shock to his heart. It felt like being kicked in the chest by a horse.
[More]
Feb 05, 2000
A Food and Drug Administration advisory committee recommended approval of Ventritex Inc.'s heart defibrillator for controlling abnormal heart rhythms. The device, the Cadence V-100 implantable defibrillator, is Ventritex's primary product. It emits regular electrical impulses to pace the heart and sends electrical shocks of varied strength to correct irregularities.
[More]
|
 |
|||||
 |
|
 |
|||
 |
 |